Found 39 matching trials
Serplulimab With Chemoradiotherapy for Postoperative Cervical Cancer With Risk Factors PHASE2 A Phase II Study of Serplulimab Plus Chemoradiotherapy as Adjuvant Treatmen...
Show More Location
Tianjin Medical University Cancer Institute & Hospital
Learn More & Join Trial
Serplulimab Combined With Chemotherapy in Patients With Resectable Esophageal Squamous Cell Carcinoma PHASE2 China with high incidence of esophageal cancer, the number of new cases and...
Show More Status
Active Not Recruiting
Location
2nd Affiliated Hospital, School of Medicine, Zhejiang University
Learn More & Join Trial
Neoadjuvant Chemoradiotherapy Combined With Immunotherapy and Anti-angiogenesis in Treating Locally Advanced Rectal Cancer PHASE2 This is a multicenter, prospective, randomized phase II trial designed to e...
Show More Location
Department of Colorectal Surgery in Changhai Hospital
Learn More & Join Trial
Efficacy and Safety of Serplulimab With Chemotherapy and Aspirin in Untreated Extensive-Stage Small Cell Lung Cancer PHASE2 Lung cancer remains a leading cause of cancer-related deaths worldwide, wit...
Show More Location
Multiple Locations
Learn More & Join Trial
NCT + PD1 + Ketogenic Diet and/or Vitamin C for LARC PHASE2 To explore the efficacy and safety of adding a ketogenic diet and/or high-d...
Show More Location
Sixth Affiliated Hospital, Sun Yat-sen University
Learn More & Join Trial
NK Cells Plus ICI for SCLC Maintenance PHASE2 This research study is designed for patients with extensive-stage small cel...
Show More Location
Tianjin First Central Hospital
Learn More & Join Trial
Serplulimab Combined With Cryoablation for Early-Stage Non-Small Cell Lung Cancer PHASE2 The goal of this clinical trial is to learn if serplulimab combined with cr...
Show More Location
Zhongshan Hospital Affiliated to Fudan University, No. 180 Fenglin Road, Xuhui District,
Learn More & Join Trial
Neoadjuvant Moderately Hypofractionated Radiotherapy Combined with Chemotherapy and Immunotherapy for High-risk LARC PHASE2 This study aims to evaluate the effectiveness and safety of combining moder...
Show More Location
Zhongshan Hospital, Fudan University
Learn More & Join Trial
Phase I Clinical Study of Tumor-associated Lymph Node T Cell Therapy for Advanced Solid Tumors PHASE1 A total of 17 to 23 participants are anticipated to be enrolled in the Phas...
Show More Location
Sun Yat-sen University Cancer Center
Learn More & Join Trial
A Prospective, Multicenter, Single-Arm Phase II Exploratory Study of Serplulimab Combined With Oncolytic Virus H101, Short-Course Radiotherapy, and XELOX Chemotherapy as Total Neoadjuvant Treatment for Locally Advanced (cT1-3N0M0) Rectal Cancer PHASE2 This study aims to evaluate the safety and effectiveness of a combination t...
Show More Location
Chongqing University Cancer Hospital
Learn More & Join Trial